Compugen Ltd. diskutieren
Compugen Ltd.
WKN: 553001 / Symbol: CGEN / Name: Compugen / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
1,46 €
14,44 %
Compugen Ltd. (NASDAQ: CGEN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $4.00 price target on the stock.
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) had its price target raised by analysts at Stifel Nicolaus from $3.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) had its price target lowered by analysts at Truist Financial Co. from $5.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $4.00 price target on the stock.
Ratings data for CGEN provided by MarketBeat
Neueste Beiträge
Roth_Capital in Discuss Vicor Corp.